NPM1 and dyskeratosis congenita: In the same study with NPM1, it was also reported that dyskeratosis congenita patient cells with NPM1 D178H mutation resulted in reduced 2’-O-Me at specific sites and decreased IRES-dependent translation without changes in nucleolar localization of NPM1 D178H57.